Posts
| ||
| Diet Drugs Get a New Slim Chance at Approval Forbes Contrave, the investigational diet pill combination of naltrexone and bupropion, has been granted a possible new lease on life by the FDA. In January of this year the FDA issued a complete response letter to Orexigen, the drug's sponsor. ... See all stories on this topic » | ||
| Go Green: When to buy organic fruits and veggies Siftings Herald For most people, though, an all-organic diet would be both expensive and impractical. If you're concerned about your food but your grocery budget and shopping options are limited, take heart. The Environmental Working Group recently updated its handy ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment